| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.
|
J Clin Oncol
|
2007
|
2.47
|
|
2
|
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
|
Int J Radiat Oncol Biol Phys
|
2008
|
2.13
|
|
3
|
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches.
|
Head Neck
|
2011
|
1.97
|
|
4
|
Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.84
|
|
5
|
Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.79
|
|
6
|
High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
|
Radiother Oncol
|
2008
|
1.65
|
|
7
|
A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.60
|
|
8
|
Current treatment options for recurrent nasopharyngeal cancer.
|
Eur Arch Otorhinolaryngol
|
2010
|
1.48
|
|
9
|
Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.45
|
|
10
|
Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia.
|
Radiother Oncol
|
2009
|
1.40
|
|
11
|
Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
|
Int J Cancer
|
2005
|
1.39
|
|
12
|
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
|
Clin Cancer Res
|
2007
|
1.37
|
|
13
|
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery.
|
Head Neck
|
2010
|
1.34
|
|
14
|
Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
|
Radiother Oncol
|
2005
|
1.31
|
|
15
|
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study.
|
Radiother Oncol
|
2011
|
1.31
|
|
16
|
Evidence-based review of treatment options for patients with glottic cancer.
|
Head Neck
|
2011
|
1.30
|
|
17
|
Physiological interaction of heart and lung in thoracic irradiation.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.19
|
|
18
|
Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review.
|
Radiother Oncol
|
2011
|
1.14
|
|
19
|
Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.14
|
|
20
|
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
|
Head Neck
|
2011
|
1.13
|
|
21
|
Oesophageal tumour progression between the diagnostic ¹⁸F-FDG-PET and the ¹⁸F-FDG-PET for radiotherapy treatment planning.
|
Radiother Oncol
|
2012
|
1.13
|
|
22
|
The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer.
|
Oral Oncol
|
2009
|
1.12
|
|
23
|
3D Variation in delineation of head and neck organs at risk.
|
Radiat Oncol
|
2012
|
1.11
|
|
24
|
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
|
Radiother Oncol
|
2011
|
1.11
|
|
25
|
Health status and voice outcome after treatment for T1a glottic carcinoma.
|
Eur Arch Otorhinolaryngol
|
2004
|
1.11
|
|
26
|
Quality of life after surgical treatment for oral and oropharyngeal cancer: a prospective longitudinal assessment of patients reconstructed by a microvascular flap.
|
Oral Oncol
|
2007
|
1.10
|
|
27
|
The impact of heart irradiation on dose-volume effects in the rat lung.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.09
|
|
28
|
The efficacy of voice therapy in patients after treatment for early glottic carcinoma.
|
Cancer
|
2006
|
1.07
|
|
29
|
Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience.
|
Oral Oncol
|
2006
|
1.06
|
|
30
|
Health-related quality of life in patients surviving non-small cell lung cancer.
|
Thorax
|
2010
|
1.05
|
|
31
|
Proposal for a rational classification of neck dissections.
|
Head Neck
|
2010
|
1.04
|
|
32
|
Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality.
|
Head Neck
|
2007
|
1.04
|
|
33
|
Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma.
|
Eur Arch Otorhinolaryngol
|
2012
|
1.03
|
|
34
|
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
|
Radiother Oncol
|
2012
|
1.03
|
|
35
|
Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.01
|
|
36
|
Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care.
|
Oral Oncol
|
2013
|
1.01
|
|
37
|
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.
|
Eur Arch Otorhinolaryngol
|
2012
|
1.00
|
|
38
|
The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.
|
Oncologist
|
2011
|
1.00
|
|
39
|
A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
|
Radiother Oncol
|
2010
|
1.00
|
|
40
|
Primary treatment of the anterior vocal commissure squamous carcinoma.
|
Eur Arch Otorhinolaryngol
|
2006
|
0.99
|
|
41
|
Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.99
|
|
42
|
Changes in nutritional status and dietary intake during and after head and neck cancer treatment.
|
Head Neck
|
2010
|
0.99
|
|
43
|
Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.
|
Eur Arch Otorhinolaryngol
|
2003
|
0.99
|
|
44
|
Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient?
|
Laryngoscope
|
2005
|
0.98
|
|
45
|
Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.98
|
|
46
|
Does screening for distress efficiently uncover meetable unmet needs in cancer patients?
|
Psychooncology
|
2011
|
0.98
|
|
47
|
Swallowing after major surgery of the oral cavity or oropharynx: a prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction.
|
Head Neck
|
2007
|
0.98
|
|
48
|
The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence?
|
Acta Otolaryngol
|
2007
|
0.97
|
|
49
|
More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life.
|
Nutr Cancer
|
2013
|
0.97
|
|
50
|
Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer.
|
Radiother Oncol
|
2009
|
0.96
|
|
51
|
Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.96
|
|
52
|
Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.
|
Radiother Oncol
|
2010
|
0.96
|
|
53
|
Management of salivary gland tumors.
|
Expert Rev Anticancer Ther
|
2012
|
0.95
|
|
54
|
Enhanced proliferation of acinar and progenitor cells by prophylactic pilocarpine treatment underlies the observed amelioration of radiation injury to parotid glands.
|
Radiother Oncol
|
2009
|
0.95
|
|
55
|
Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment.
|
Oral Oncol
|
2012
|
0.94
|
|
56
|
Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.93
|
|
57
|
Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival.
|
Radiother Oncol
|
2011
|
0.92
|
|
58
|
The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study.
|
Radiother Oncol
|
2011
|
0.92
|
|
59
|
Statistical validation of normal tissue complication probability models.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.92
|
|
60
|
Protons in head-and-neck cancer: bridging the gap of evidence.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.92
|
|
61
|
Multivariate modeling of complications with data driven variable selection: guarding against overfitting and effects of data set size.
|
Radiother Oncol
|
2012
|
0.92
|
|
62
|
Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
|
Radiother Oncol
|
2011
|
0.92
|
|
63
|
Conducting radiogenomic research--do not forget careful consideration of the clinical data.
|
Radiother Oncol
|
2012
|
0.92
|
|
64
|
Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.
|
Eur Arch Otorhinolaryngol
|
2013
|
0.92
|
|
65
|
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
|
J Nucl Med
|
2013
|
0.91
|
|
66
|
External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy.
|
Radiother Oncol
|
2011
|
0.91
|
|
67
|
Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
|
Cancer
|
2006
|
0.91
|
|
68
|
Quality of life among prostate cancer patients: a prospective longitudinal population-based study.
|
Radiother Oncol
|
2013
|
0.91
|
|
69
|
The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia.
|
Acta Oncol
|
2013
|
0.91
|
|
70
|
The impact of comorbidity on treatment-related side effects in older patients with laryngeal cancer.
|
Oral Oncol
|
2010
|
0.91
|
|
71
|
Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: a review.
|
Clin Nucl Med
|
2014
|
0.90
|
|
72
|
The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy.
|
Oral Oncol
|
2011
|
0.90
|
|
73
|
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
|
J Clin Oncol
|
2011
|
0.90
|
|
74
|
Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up.
|
J Clin Oncol
|
2012
|
0.90
|
|
75
|
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.
|
J Clin Oncol
|
2012
|
0.90
|
|
76
|
Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
|
Head Neck
|
2009
|
0.90
|
|
77
|
Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.
|
Cancer Treat Rev
|
2011
|
0.89
|
|
78
|
The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
|
Acta Oncol
|
2012
|
0.89
|
|
79
|
Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.89
|
|
80
|
Permanent unilateral hearing loss after radiotherapy for parotid gland tumors.
|
Head Neck
|
2006
|
0.88
|
|
81
|
External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
|
Radiother Oncol
|
2011
|
0.88
|
|
82
|
Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
|
Eur J Radiol
|
2006
|
0.88
|
|
83
|
Quality of life as predictor of survival: a prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer.
|
Radiother Oncol
|
2010
|
0.87
|
|
84
|
Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer.
|
Radiother Oncol
|
2010
|
0.87
|
|
85
|
Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.87
|
|
86
|
Electronic portal images (EPIs) based position verification for the breast simultaneous integrated boost (SIB) technique.
|
Radiother Oncol
|
2011
|
0.87
|
|
87
|
Recent changes in the treatment of patients with advanced laryngeal cancer.
|
Head Neck
|
2008
|
0.86
|
|
88
|
Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
|
Radiother Oncol
|
2006
|
0.86
|
|
89
|
Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
|
Ann Surg Oncol
|
2012
|
0.86
|
|
90
|
Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
|
Cancer
|
2006
|
0.86
|
|
91
|
Multimodal guided self-help exercise program to prevent speech, swallowing, and shoulder problems among head and neck cancer patients: a feasibility study.
|
J Med Internet Res
|
2014
|
0.86
|
|
92
|
Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction.
|
Radiother Oncol
|
2013
|
0.85
|
|
93
|
Do patients trust their physician? The role of attachment style in the patient-physician relationship within one year after a cancer diagnosis.
|
Acta Oncol
|
2012
|
0.85
|
|
94
|
Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma.
|
J Gynecol Oncol
|
2011
|
0.85
|
|
95
|
Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
|
Radiother Oncol
|
2013
|
0.85
|
|
96
|
Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.
|
Radiother Oncol
|
2008
|
0.85
|
|
97
|
Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapy.
|
Cancer Treat Rev
|
2012
|
0.85
|
|
98
|
The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.85
|
|
99
|
Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction.
|
Oral Oncol
|
2005
|
0.85
|
|
100
|
Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging.
|
Radiology
|
2004
|
0.85
|
|
101
|
Indications for radiotherapy after neck dissection.
|
Head Neck
|
2010
|
0.85
|
|
102
|
The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.
|
Radiother Oncol
|
2012
|
0.84
|
|
103
|
Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice.
|
Support Care Cancer
|
2012
|
0.84
|
|
104
|
Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.84
|
|
105
|
Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.
|
Radiother Oncol
|
2013
|
0.84
|
|
106
|
Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.84
|
|
107
|
Speech outcome after surgical treatment for oral and oropharyngeal cancer: a longitudinal assessment of patients reconstructed by a microvascular flap.
|
Head Neck
|
2005
|
0.84
|
|
108
|
Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.84
|
|
109
|
The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.
|
Oral Oncol
|
2005
|
0.83
|
|
110
|
Early-stage young breast cancer patients: impact of local treatment on survival.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.83
|
|
111
|
Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.83
|
|
112
|
Efficacy of routine pre-radiation dental screening and dental follow-up in head and neck oncology patients on intermediate and late radiation effects. A retrospective evaluation.
|
Radiother Oncol
|
2011
|
0.83
|
|
113
|
Incidence, causative mechanisms, and anatomic localization of stroke in pituitary adenoma patients treated with postoperative radiation therapy versus surgery alone.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.82
|
|
114
|
Optimum dose range for the amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment.
|
Radiother Oncol
|
2007
|
0.81
|
|
115
|
Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy.
|
Radiat Oncol
|
2008
|
0.81
|
|
116
|
The Groningen Radiotherapy-Induced Xerostomia questionnaire: development and validation of a new questionnaire.
|
Radiother Oncol
|
2010
|
0.81
|
|
117
|
Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
|
Radiother Oncol
|
2008
|
0.81
|
|
118
|
FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.80
|
|
119
|
Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study.
|
Oral Oncol
|
2011
|
0.80
|
|
120
|
Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma.
|
Eur Arch Otorhinolaryngol
|
2006
|
0.80
|
|
121
|
Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.80
|
|
122
|
Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
|
Laryngoscope
|
2013
|
0.80
|
|
123
|
Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas.
|
Eur Arch Otorhinolaryngol
|
2006
|
0.80
|
|
124
|
Re-irradiation of a second localization of idiopathic midline destructive disease in the head and neck area.
|
Eur Arch Otorhinolaryngol
|
2007
|
0.80
|
|
125
|
High and low LET radiation differentially induce normal tissue damage signals.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.80
|
|
126
|
Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
|
Head Neck
|
2014
|
0.79
|
|
127
|
Patient position verification with oblique radiation beams.
|
Radiother Oncol
|
2007
|
0.79
|
|
128
|
Comparison of normal tissue dose with three-dimensional conformal techniques for breast cancer irradiation including the internal mammary nodes.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.79
|
|
129
|
Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma.
|
Eur Radiol
|
2008
|
0.79
|
|
130
|
Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma.
|
Oral Oncol
|
2012
|
0.79
|
|
131
|
Limited benefit of inversely optimised intensity modulation in breast conserving radiotherapy with simultaneously integrated boost.
|
Radiother Oncol
|
2010
|
0.79
|
|
132
|
Validity of bioelectrical impedance analysis to assess fat-free mass in patients with head and neck cancer: an exploratory study.
|
Head Neck
|
2014
|
0.79
|
|
133
|
MR imaging predictors of local control of glottic squamous cell carcinoma treated with radiation alone.
|
Radiology
|
2007
|
0.78
|
|
134
|
Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation.
|
Radiother Oncol
|
2009
|
0.78
|
|
135
|
Quantifying local radiation-induced lung damage from computed tomography.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.78
|
|
136
|
Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
|
Radiother Oncol
|
2007
|
0.78
|
|
137
|
An in silico comparison between margin-based and probabilistic target-planning approaches in head and neck cancer patients.
|
Radiother Oncol
|
2013
|
0.78
|
|
138
|
Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.
|
Radiother Oncol
|
2013
|
0.78
|
|
139
|
Contemporary management of sinonasal cancer.
|
Head Neck
|
2010
|
0.78
|
|
140
|
Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer.
|
Folia Phoniatr Logop
|
2009
|
0.78
|
|
141
|
Synergistic induction of profibrotic PAI-1 by TGF-β and radiation depends on p53.
|
Radiother Oncol
|
2010
|
0.77
|
|
142
|
Resting energy expenditure in head and neck cancer patients before and during radiotherapy.
|
Clin Nutr
|
2012
|
0.77
|
|
143
|
In Response to: Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.77
|
|
144
|
Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
|
Eur J Cancer
|
2013
|
0.77
|
|
145
|
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase I.
|
Head Neck
|
2012
|
0.77
|
|
146
|
Volume-dependent expression of in-field and out-of-field effects in the proton-irradiated rat lung.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.77
|
|
147
|
18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.77
|
|
148
|
Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
|
Radiother Oncol
|
2011
|
0.77
|
|
149
|
Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas.
|
Radiother Oncol
|
2005
|
0.77
|
|
150
|
Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer.
|
J Voice
|
2011
|
0.77
|
|
151
|
Lymph node metastasis in nasal vestibule cancer: a review.
|
Head Neck
|
2010
|
0.76
|
|
152
|
ΔNp73 enhances promoter activity of TGF-β induced genes.
|
PLoS One
|
2012
|
0.76
|
|
153
|
Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients.
|
Breast Cancer Res Treat
|
2014
|
0.76
|
|
154
|
Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma.
|
Eur Arch Otorhinolaryngol
|
2012
|
0.76
|
|
155
|
Tyrosine positron emission tomography and protein synthesis rate in pituitary adenoma: different effects of surgery and radiation therapy.
|
Radiother Oncol
|
2011
|
0.76
|
|
156
|
A screening questionnaire for voice problems after treatment of early glottic cancer.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.76
|
|
157
|
Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.76
|
|
158
|
Hypopharyngeal carcinoma after radiation for tuberculosis: radiation-induced carcinoma.
|
Oral Oncol
|
2010
|
0.76
|
|
159
|
Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night.
|
Radiother Oncol
|
2013
|
0.76
|
|
160
|
18F-FLT-PET for detection of rectal cancer.
|
Radiother Oncol
|
2011
|
0.76
|
|
161
|
Artificial neural network analysis to assess hypernasality in patients treated for oral or oropharyngeal cancer.
|
Logoped Phoniatr Vocol
|
2011
|
0.75
|
|
162
|
Associations between voice quality and swallowing function in patients treated for oral or oropharyngeal cancer.
|
Support Care Cancer
|
2013
|
0.75
|
|
163
|
Development of a facility for high-precision irradiation of cells with carbon ions.
|
Med Phys
|
2011
|
0.75
|
|
164
|
External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy.
|
Head Neck
|
2007
|
0.75
|
|
165
|
Scrotal irradiation in primary testicular lymphoma: review of the literature and in silico planning comparative study.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.75
|
|
166
|
The effect of induction chemotherapy on tumor volume and organ-at-risk doses in patients with locally advanced oropharyngeal cancer.
|
Radiother Oncol
|
2013
|
0.75
|
|
167
|
Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
|
Tumori
|
2014
|
0.75
|
|
168
|
Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer.
|
Head Neck
|
2013
|
0.75
|